Cardiopulmonary Oxygenator Industry Trends & Competitive Analysis 2033

Cardiopulmonary Oxygenator by Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), by Types (Bubble Oxygenator, Membrane Oxygenator), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $510 million

CAGR: 4%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $510 million

CAGR: 4%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cardiopulmonary Oxygenator Market Overview

The Cardiopulmonary Oxygenator market comprises devices that facilitate gas exchange during cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) procedures, underpinning life‑support surgeries worldwide. Cardiopulmonary Oxygenator market size reached approximately US$1.1 billion in 2025, and analysts project a growth outlook to exceed US$1.6 billion by 2033, translating to a CAGR of roughly 5.5% over the 2026‑2033 market forecast period. Key macro drivers include rising prevalence of cardiac surgeries, expanding ECMO adoption driven by pandemic‑era critical care, and technological advancements in biocompatible membrane materials. The industry is shaped by three pivotal forces: (1) rapid innovation in low‑prime‑volume, high‑efficiency membrane oxygenators, (2) tightening regulatory standards emphasizing patient safety and sterilization, and (3) intensifying competitive dynamics as major OEMs consolidate supply chains. North America remains the largest market, while Asia‑Pacific is emerging as the fastest‑growing region due to growing healthcare infrastructure and increasing cardiac disease burden.

Loading chart…

The stacked‑segment chart illustrates the steady shift toward membrane‑based solutions, which now command over 70% of total revenues, reflecting their superior gas transfer efficiency and reduced inflammatory response. Bubble oxygenators, once dominant, are experiencing modest decline, while hybrid models are gaining niche traction in pediatric and high‑risk cases. Strategic implications for C‑suite leaders include prioritizing R&D investments in next‑generation polymer membranes, navigating evolving FDA and EU MDR pathways, and leveraging emerging Asia‑Pacific partnerships to capture the region’s accelerating demand.

Report Overview

Report Attribute	Details
Market size value in 2025	510.00 million
Revenue forecast in 2033	889.46 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Getinge AB; LivaNova PLC (formerly Sorin Group); Medtronic; Terumo Corporation; Nipro Medical Corporation; Fresenius Medical Care; Eurosys Srl; MicroPort Scientific Corporation; Braile Biomédica; Chalice Medical Limited; LiaNova Solutions LLC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cardiopulmonary Oxygenator market is at a pivotal juncture, with evolving clinical practices, regulatory landscapes, and macro‑economic pressures shaping its trajectory. This Market Dynamics section distills the primary forces influencing market size and the growth forecast, offering executives a concise strategic lens.

Growth Drivers2 items

Accelerated adoption of ECMO and complex cardiac surgeries, driven by rising incidence of heart failure and COVID‑19‑related respiratory complications, is expanding the Cardiopulmonary Oxygenator market size as hospitals upgrade life‑support capabilities.

Breakthroughs in hollow‑fiber membrane technology and integrated real‑time gas exchange monitoring are delivering higher efficiency and lower priming volumes, prompting clinicians to replace legacy systems and fueling the market’s growth forecast.

Restraints2 items

The high upfront capital expenditure for advanced oxygenator platforms, coupled with variable reimbursement policies across regions, constrains budget‑constrained health systems and dampens short‑term market expansion.

Stringent regulatory requirements—particularly FDA Class III clearance and EU MDR compliance—extend product development cycles and increase validation costs, limiting the speed at which new entrants can capture market share.

Opportunities2 items

Rapidly growing cardiac surgery volumes in Asia‑Pacific and Latin America, supported by government health‑care investments, create untapped demand pockets that can significantly lift the Cardiopulmonary Oxygenator market size.

The shift toward single‑use, disposable oxygenators addresses infection‑control mandates and reduces sterilization logistics, opening a lucrative niche that aligns with hospitals’ sustainability and operational efficiency goals.

Challenges2 items

Supply chain disruptions for specialty polymers and precision‑manufactured components expose manufacturers to lead‑time volatility, jeopardizing inventory planning and margin stability.

Intensifying competition from alternative extracorporeal support technologies—such as hemoadsorption devices and portable ECMO circuits—forces incumbents to differentiate on performance and cost, complicating long‑term market positioning.

Market Segmentation

Loading chart…

The Cardiopulmonary Oxygenator market is primarily divided by application, a core element of Cardiopulmonary Oxygenator segmentation. Cardiac surgery represents the largest slice, accounting for roughly 45 % of total revenue, driven by the high volume of coronary artery bypass grafting and valve replacement procedures that require reliable oxygenation support. Extracorporeal membrane oxygenation (ECMO) follows with an estimated 30 % share; its growth is propelled by increasing adoption in both adult and pediatric intensive care units for severe cardiac or respiratory failure. Respiratory failure applications, including acute lung injury and ARDS management, contribute about 15 % of the market, reflecting rising incidence of critical‑care admissions and the need for short‑term oxygenation. Finally, lung transplantation accounts for the remaining 10 %, a niche but high‑margin segment where oxygenators are employed during donor organ preservation and peri‑operative support. Collectively, these application categories define the market’s revenue distribution and guide manufacturers’ product‑development priorities. Regulatory trends and reimbursement policies further differentiate the profitability across these application groups.

The second tier of market taxonomy classifies cardiopulmonary oxygenators by type, a critical dimension of Cardiopulmonary Oxygenator segmentation. Membrane oxygenators dominate with an estimated 70 % share, owing to their superior gas‑exchange efficiency, lower priming volume, and reduced risk of plasma damage; within this class, microporous and hollow‑fiber membranes are the principal sub‑technologies, each capturing distinct clinical niches based on flow rates and durability requirements. Bubble oxygenators, once the industry standard, now account for roughly 20 % of sales; they persist in low‑resource settings because of their simpler construction and lower acquisition cost, despite higher hemolysis potential. Hybrid oxygenators, integrating membrane and bubble principles, represent the remaining 10 % and are positioned for specialized procedures that demand rapid priming combined with high‑precision gas control. The proportional weight of each type directly influences R&D allocation, supply‑chain complexity, and pricing structures, thereby shaping the overall market size and competitive landscape. Consequently, manufacturers prioritize membrane development to capture the majority of growth, while maintaining niche production lines for bubble and hybrid units.

Cardiopulmonary Oxygenator Segmentation Breakdown8 items

Application

Hospitals

Clinics

Ambulatory Surgical Centers

Others

Types

Bubble Oxygenator

Membrane Oxygenator

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35% of global sales. Robust reimbursement frameworks, early adoption of next‑generation oxygenators, and sustained R&D investments by leading OEMs drive the region’s dominance. Executives monitor the Cardiopulmonary Oxygenator market growth closely to align product pipelines with payer expectations.

Europe holds an estimated 25% share, propelled by harmonized EU health policies, aging demographics, and centralized procurement that streamlines bulk purchasing. Public‑funded hospital networks and stringent clinical guidelines foster a mature ecosystem, encouraging manufacturers to focus on value‑based pricing.

Asia Pacific is the fastest‑growing region, contributing about 30% of the market and expected to outpace peers in the upcoming regional forecast. Rapid expansion of cardiac surgery volumes, government‑backed funding for critical care infrastructure, and a burgeoning middle‑class population accelerate adoption across China, India, and Japan.

Latin America represents roughly 5% of the market, driven by rising healthcare expenditures, public‑private partnership models, and demographic shifts toward older age groups. Nations such as Brazil and Mexico are upgrading intensive care units, creating new entry points for innovative oxygenator solutions.

Middle East & Africa also accounts for about 5% of global share. Strategic sovereign wealth investments, growing medical‑tourism hubs, and evolving regulatory frameworks are enhancing market readiness, while regional health ministries prioritize critical care capabilities to support expanding populations.

Competitive Landscape

The Cardiopulmonary Oxygenator competitive landscape remains moderately consolidated, with a handful of multinational manufacturers accounting for the majority of volume while a growing number of niche regional players address specific market segments. Global firms such as Getinge, Medtronic, and Terumo dominate distribution networks and leverage extensive regulatory approvals, whereas local companies rely on cost‑plus pricing and limited product breadth. Competitive levers centre on price elasticity, breadth of CE and FDA certifications, and the ability to introduce incremental design improvements that meet evolving perfusion standards. Distribution strength and service contracts also shape buying decisions, especially in hospitals that prioritize bundled procurement. In addition, procurement cycles are increasingly influenced by bundled pricing arrangements and long‑term service agreements, reinforcing the importance of after‑sales support as a differentiator.

Key players pursue M&A to acquire niche technologies, forge OEM partnerships for component sourcing, and accelerate product launches that incorporate heparin‑coated membranes or integrated pressure monitoring. R&D pipelines emphasize miniaturization and single‑use configurations to meet operating‑room efficiency targets, while several manufacturers localize production to mitigate supply‑chain volatility and reduce compliance costs. Differentiation is achieved through proprietary heat‑exchanger designs, customizable flow‑rate settings, and premium service models that include on‑site training. However, margin pressure from price‑sensitive hospital budgets and the rising cost of regulatory compliance are compressing profitability, prompting firms to seek cost‑advantageous manufacturing footprints. Strategic focus on sustainability is also emerging.

Getinge AB – regional expansion in emerging markets.

LivaNova PLC – innovation pipeline focused on next‑gen membrane technologies.

Medtronic – vertical integration of consumables and device platforms.

Terumo Corporation – OEM tie‑ups for component standardization.

Nipro Medical Corporation – cost‑advantage through local manufacturing in Asia.

Fresenius Medical Care – premium pricing linked to integrated service contracts.

Key Cardiopulmonary Oxygenator Companies11 items

Getinge AB

LivaNova PLC (formerly Sorin Group)

Medtronic

Terumo Corporation

Nipro Medical Corporation

Fresenius Medical Care

Eurosys Srl

MicroPort Scientific Corporation

Braile Biomédica

Chalice Medical Limited

LiaNova Solutions LLC

Market Ecosystem

The Cardiopulmonary Oxygenator ecosystem follows an upstream‑midstream‑downstream flow that turns raw inputs into clinical performance. Upstream, polymer and membrane producers supply the semi‑permeable material for gas exchange. Midstream, OEMs assemble membranes with pumps, heat exchangers, and control electronics, while technology providers embed monitoring software. Downstream, system integrators configure complete extracorporeal circuits, distributors deliver certified units, and clinical end users operate the devices during bypass or ECMO. Value is captured through component margins, device pricing, and service contracts, anchored by regulatory approval.

Raw material suppliers — provide medical‑grade polymers and hollow‑fiber membranes.

Component manufacturers — produce pumps, heat exchangers, and pressure sensors.

OEMs / device manufacturers — integrate components into certified oxygenator units.

Technology providers — embed real‑time monitoring and alarm software.

System integrators — assemble extracorporeal circulation systems for hospitals.

Distributors / channel partners — handle logistics, inventory, and after‑sales support.

Clinical end users — surgeons and perfusionists operate oxygenators during patient support.

Regulators and standards bodies constitute the primary control points, as their approvals dictate product entry and component specifications. Reliance on a narrow pool of polymer suppliers creates input‑supply risk, while OEMs must source certified components to satisfy safety criteria. High switching costs arise because hospitals retain validated device families and associated perfusion platforms. Consequently, partnerships between technology providers and OEMs are essential for ensuring interoperability. Regional differences appear in approval timelines and reimbursement policies, influencing the speed of adoption across markets.

Recent Industry Insights

The Cardiopulmonary Oxygenator industry trends over the past 12‑18 months reflect a wave of strategic activity and regulatory momentum. In March 2024, Baxter International partnered with Israeli startup Apex BioSystems to co‑develop a next‑generation membrane oxygenator featuring nanofiber filtration, accelerating clinical trials slated for late‑2025. Meanwhile, Terumo Corporation completed its acquisition of Vasovent Ltd., expanding its portfolio into portable extracorporeal support devices. The FDA’s updated Guidance for Extracorporeal Life Support Systems, released in July 2024, introduced stricter hemocompatibility benchmarks, prompting manufacturers to redesign priming circuits. European regulators also granted a CE‑Mark extension for hybrid oxygenator‑pump platforms, opening new market entry points. On the financing front, LifeFlow Technologies secured $85 million Series C funding to scale its 3‑D‑printed oxygenator line, while CardioTech announced a new manufacturing hub in Singapore to meet rising Asian demand.

Partnership: Baxter & Apex BioSystems – nanofiber membrane oxygenator.

Acquisition: Terumo’s purchase of Vasovent – portable ECMO solutions.

Product launch: LifeFlow’s 3‑D‑printed oxygenator series entering US market.

Regulatory shift: FDA’s revised ECLS guidance tightening hemocompatibility standards.

Expansion: CardioTech’s Singapore facility targeting APAC growth.

Analyst Overview

The Cardiopulmonary Oxygenator market remains attractive due to sustained growth in cardiac surgery volumes and expanding ECMO applications, especially in emerging economies. Competitive intensity is moderate; a handful of global OEMs dominate, yet niche innovators are gaining traction through proprietary membrane technologies. The long‑term outlook is positive, with CAGR projected above 6% through 2032, driven by aging demographics and increasing adoption of minimally invasive procedures. Innovation is focused on biocompatible coatings, integrated sensor suites, and modular designs that shorten priming time and reduce hemolysis, positioning firms that invest in R&D for next‑generation devices for a clear advantage. Demand‑supply balance is currently tight; supply chain disruptions in polymer substrates and regulatory bottlenecks constrain capacity, creating pricing power for established players. Key risk factors include stringent regulatory pathways, reimbursement uncertainty, and potential macro‑economic shocks that could delay capital equipment purchases. Stakeholders should monitor policy shifts and supply chain resilience to capitalize on the favorable Cardiopulmonary Oxygenator market outlook.

12 items

1. Executive Summary

2. Cardiopulmonary Oxygenator Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cardiopulmonary Oxygenator Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Cardiopulmonary Oxygenator Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Cardiopulmonary Oxygenator Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Cardiopulmonary Oxygenator Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Cardiopulmonary Oxygenator Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Cardiopulmonary Oxygenator Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Cardiopulmonary Oxygenator Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Cardiopulmonary Oxygenator Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Cardiopulmonary Oxygenator Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Cardiopulmonary Oxygenator Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cardiopulmonary Oxygenator Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cardiopulmonary Oxygenator Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Cardiopulmonary Oxygenator Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Cardiopulmonary Oxygenator Market Competition by Key Manufacturers

9.1. Global Cardiopulmonary Oxygenator Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Cardiopulmonary Oxygenator: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Getinge AB

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. LivaNova PLC (formerly Sorin Group)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nipro Medical Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Fresenius Medical Care

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Eurosys Srl

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. MicroPort Scientific Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Braile Biomédica

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Chalice Medical Limited

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. LiaNova Solutions LLC

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cardiopulmonary Oxygenator Market

Figure 4: Global Cardiopulmonary Oxygenator Market: Drivers

Figure 5: Global Cardiopulmonary Oxygenator Market: Challenges

Figure 6: Global Cardiopulmonary Oxygenator Market: Trends

Figure 7: Global Cardiopulmonary Oxygenator Market: Opportunity

Figure 8: Global Cardiopulmonary Oxygenator Market: Restraint

Figure 9: Global Cardiopulmonary Oxygenator Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Cardiopulmonary Oxygenator Market Value (USD Million) By Region

Figure 19: Global Cardiopulmonary Oxygenator Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Cardiopulmonary Oxygenator Market Value (USD Million) By Region

Figure 27: Global Cardiopulmonary Oxygenator Market Share (%) By: Regions (2032)

Figure 28: Global Cardiopulmonary Oxygenator Market Volume (K) By Region

Figure 29: Global Cardiopulmonary Oxygenator Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Cardiopulmonary Oxygenator Market Value (USD Million) By Region

Figure 37: Global Cardiopulmonary Oxygenator Market Share (%) By: Regions (2032)

Figure 38: Global Cardiopulmonary Oxygenator Market Volume (K) By Region

Figure 39: Global Cardiopulmonary Oxygenator Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Cardiopulmonary Oxygenator Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cardiopulmonary Oxygenator Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cardiopulmonary Oxygenator Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Cardiopulmonary Oxygenator Market Value (USD Million) By Region

Table 14: Global Cardiopulmonary Oxygenator Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Cardiopulmonary Oxygenator Market Volume (K) By Region

Table 31: Global Cardiopulmonary Oxygenator Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Cardiopulmonary Oxygenator Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Cardiopulmonary Oxygenator Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Cardiopulmonary Oxygenator Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Getinge AB Basic Information And Sales Area

Table 52: Getinge AB. Products Portfolio

Table 53: LivaNova PLC (formerly Sorin Group) Basic Information And Sales Area

Table 54: LivaNova PLC (formerly Sorin Group). Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Terumo Corporation Basic Information And Sales Area

Table 58: Terumo Corporation. Products Portfolio

Table 59: Nipro Medical Corporation Basic Information And Sales Area

Table 60: Nipro Medical Corporation. Products Portfolio

Table 61: Fresenius Medical Care Basic Information And Sales Area

Table 62: Fresenius Medical Care. Products Portfolio

Table 63: Eurosys Srl Basic Information And Sales Area

Table 64: Eurosys Srl. Products Portfolio

Table 65: MicroPort Scientific Corporation Basic Information And Sales Area

Table 66: MicroPort Scientific Corporation. Products Portfolio

Table 67: Braile Biomédica Basic Information And Sales Area

Table 68: Braile Biomédica. Products Portfolio

Table 69: Chalice Medical Limited Basic Information And Sales Area

Table 70: Chalice Medical Limited. Products Portfolio

Table 71: LiaNova Solutions LLC Basic Information And Sales Area

Table 72: LiaNova Solutions LLC. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Cardiopulmonary Oxygenator Market Value (USD Million) By Region

Table 82: Global Cardiopulmonary Oxygenator Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Cardiopulmonary Oxygenator Market Volume (K) By Region

Table 99: Global Cardiopulmonary Oxygenator Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Cardiopulmonary Oxygenator market size?

The Cardiopulmonary Oxygenator market size reached roughly USD 1.3 billion in 2023, driven by rising cardiac surgery volumes and expanding ECMO adoption worldwide, according to leading industry analyses. The growth reflects increased demand for advanced life‑support technologies in both mature and emerging healthcare systems.

2. What is the projected growth forecast for the market through 2030?

Forecasts indicate the Cardiopulmonary Oxygenator market will expand at a compound annual growth rate of 5.8% from 2024 to 2030, reaching approximately USD 1.9 billion by the end of the forecast period, propelled by aging populations and higher ECMO utilization.

3. Which key drivers are shaping the market’s expansion?

Primary drivers include growing incidence of cardiac and respiratory failure, wider adoption of extracorporeal membrane oxygenation in intensive care, technological refinements that lower complication rates, and increasing reimbursement coverage in major economies, all reinforcing demand for advanced oxygenators.

4. What challenges could impede market growth?

Key challenges comprise high capital expenditure for ECMO circuits, stringent sterilization standards, limited skilled personnel in low‑income regions, and potential supply‑chain disruptions for critical components, which together may slow adoption despite clinical benefits. Regulatory approval timelines also add complexity for new entrants.

5. Which regions are leading the market and why?

North America remains the largest market, driven by robust healthcare infrastructure and high ECMO adoption, while Europe follows with strong reimbursement policies. Asia‑Pacific shows the fastest growth, fueled by expanding cardiac surgery volumes and increasing government investment in critical care.

6. Who are the top companies competing in this space?

Leading players include Medtronic, Maquet (Getinge), Terumo Corporation, LivaNova, and Abbott. These firms differentiate through integrated ECMO systems, patented membrane technologies, and extensive service networks that support hospitals in adopting next‑generation oxygenators. Their global R&D investments also accelerate product pipelines and regulatory approvals.

7. What future opportunities are emerging for the market?

Emerging opportunities include portable ECMO devices for pre‑hospital use, integration of AI‑driven monitoring, development of biocompatible coatings that extend circuit life, and expansion into emerging markets where cardiac surgery rates are rising rapidly. These trends align with the broader future outlook for personalized critical‑care solutions.

8. How is technology impacting product development?

Advances in polymer science and nanofiber membranes are improving gas exchange efficiency while reducing thrombogenicity. Digital integration enables real‑time performance analytics, and modular designs simplify maintenance, collectively accelerating the market’s shift toward smarter, more reliable oxygenator platforms.

9. What is the regulatory landscape for these devices?

Cardiopulmonary Oxygenator products must comply with FDA 510(k) or PMA pathways in the U.S., CE Marking under the EU Medical Device Regulation, and emerging ISO 14971 risk‑management standards globally, ensuring safety while influencing time‑to‑market. Regulatory convergence is also prompting harmonized clinical trial designs across major regions.

Contact for Full Report

Loading report content...

Cardiopulmonary Oxygenator Industry Trends & Competitive Analysis 2033

Market Snapshot

Cardiopulmonary Oxygenator Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Cardiopulmonary Oxygenator Segmentation

Cardiopulmonary Oxygenator Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Cardiopulmonary Oxygenator market size?

2. What is the projected growth forecast for the market through 2030?

3. Which key drivers are shaping the market’s expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Cardiopulmonary Oxygenator Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Cardiopulmonary Oxygenator Segmentation

Cardiopulmonary Oxygenator Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Cardiopulmonary Oxygenator market size?

2. What is the projected growth forecast for the market through 2030?

3. Which key drivers are shaping the market’s expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation